MeMed CEO Eran Eden, PhD, discusses the MeMed BV test and how it can help make the distinction between the types of infections, aid in patient management, and reduce antimicrobial resistance.
Eran Eden, PhD
Advertisement
Eden is MeMed's co-founder and CEO.
Articles by Eran Eden, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Ensitrelvir Becomes First Oral Option Available in US to Prevent COVID-19
2
Global Study Finds Rising Antimicrobial Resistance in Children
3
Cyclospora Outbreak Underscores Antibiotic Stewardship, C diff Risk
4
Long-Acting Injectable Buprenorphine Use Grows Unevenly Across US
5